Society guideline links: COVID-19 – Anticoagulation

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics" and "Society guideline links: Anticoagulation".)

International

●International Society on Thrombosis and Haemostasis (ISTH): Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness (2020)

●ISTH: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 (2020)

●ISTH: Interim guidance on recognition and management of coagulopathy in COVID‐19 (2020)

Canada

●Thrombosis Canada: Guidance on COVID-19 vaccines and anticoagulation (2020)

United States

●American Society of Hematology (ASH): Living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 – The use of therapeutic-intensity anticoagulation in acutely ill patients, update (2022)

●Anticoagulation Forum: Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic – Clinical guidance, update (2022)

●National Institutes of Health (NIH): COVID-19 treatment guidelines – Antithrombotic therapy in patients with COVID-19 (2022)

●American College of Chest Physicians (CHEST): Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019 – Guideline and expert panel report (2020)

United Kingdom

●Medicines and Healthcare Products Regulatory Agency (MHRA): Guidance on warfarin and other anticoagulants – Monitoring of patients during the COVID-19 pandemic (2020)